Recent Quotes (30 days)

You have no recent quotes
chg | %

ConvaTec Group PLC  

(Public, LON:CTEC)   Watch this stock  
Find more results forCTEC
211.40
-0.20 (-0.09%)
Feb 23 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 210.30 - 213.50
52 week 181.40 - 349.10
Open 211.50
Vol / Avg. 2.71M/6.28M
Mkt cap 4,115.24M*
P/E 36.38
Div/yield 1.06*
EPS 0.06*
Shares 1,951.85M
Beta     -
Inst. own     -
*GBP
May 11, 2018
ConvaTec Group PLC Annual Shareholders Meeting (Estimated) - 11:00am BST - Add to calendar
May 10, 2018
ConvaTec Group PLC Annual Shareholders Meeting Add to calendar
May 2, 2018
Q1 2018 ConvaTec Group PLC Trading Statement Release - 7:00am BST - Add to calendar
Feb 15, 2018
Full Year 2017 ConvaTec Group PLC Earnings Call - Webcast
Feb 15, 2018
Full Year 2017 ConvaTec Group PLC Earnings Release
  

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 14.38% 8.98%
Operating margin 16.61% 14.04%
EBITD margin - 24.21%
Return on average assets 7.18% 4.33%
Return on average equity 18.53% 11.44%
Employees 8,524 -
CDP Score - -

Address

3 Forbury Place Floor 7, 23 Forbury Road
ICKENHAM, RG1 3JH
United Kingdom - Map

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets. Its products include FlexiSeal Signal, FlexiSeal Fecal Collector and Intermittent Catheters.

Officers and directors

Christopher Charles Gent Chairman of the Board
Age: 68
Paul Moraviec Chief Executive Officer, Executive Director
Age: 58
Frank Schulkes Chief Financial Officer
Symeria Hudson President - Global Franchise & Innovation
Age: 49
Antonio La Regina President - EMEA Region
Age: 56
John Lindskog President - Infusion Devices & Industrial Sales
Age: 58
Timothy Moran President - Americas
Age: 44
George Poole President - APAC Region
Age: 45
Adam Brent Deutsch Executive Vice President, General Counsel
Age: 45
Marc Reuss Executive Vice President - Human Resources
Age: 56